Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
22
THRM.V Quote, Financials, Valuation and Earnings
Last price:
$0.06
Seasonality move
:
5.45%
Day range:
$0.05 - $0.05
52-week range:
$0.05 - $0.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
38.02x
P/B ratio:
2.73x
Volume:
--
Avg. volume:
40.2K
1-year change:
-82.14%
Market cap:
$2.8M
Revenue:
$80.3K
EPS (TTM):
-$0.07
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
THRM.V
Therma Bright, Inc.
|
-- | -- | -- | -- | -- |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
-- | -- | -- | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
THRM.V
Therma Bright, Inc.
|
$0.05 | -- | $2.8M | -- | $0.00 | 0% | 38.02x |
|
COOL.CX
Core One Labs, Inc.
|
$0.15 | -- | $6.8M | -- | $0.00 | 0% | 32.71x |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
HEAL.CX
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
$0.05 | -- | $9.7M | -- | $0.00 | 0% | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
$0.0200 | -- | $205.5K | 0.52x | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
THRM.V
Therma Bright, Inc.
|
-2.71% | 2.514 | 0.94% | 0.03x |
|
COOL.CX
Core One Labs, Inc.
|
-- | 0.000 | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | 0.000 | -- | -- |
|
HEAL.CX
|
-- | 0.000 | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
40.99% | -3.518 | 19.05% | 2.85x |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-3.43% | 1.456 | 20.53% | 0.00x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
THRM.V
Therma Bright, Inc.
|
-$3.3K | -$237.6K | -1957.69% | -2504.22% | -10792.66% | -$38.8K |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- | -- |
|
LOBE.CX
Lobe Sciences Ltd.
|
-- | -$1.1M | -1117.27% | -- | -- | -$408.2K |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -$72.1K | -- | -- | -- | -$92.1K |
Therma Bright, Inc. vs. Competitors
-
Which has Higher Returns THRM.V or COOL.CX?
Core One Labs, Inc. has a net margin of -10816.22% compared to Therma Bright, Inc.'s net margin of --. Therma Bright, Inc.'s return on equity of -2504.22% beat Core One Labs, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THRM.VTherma Bright, Inc.88.09% -$0.00 -$1.5M COOL.CXCore One Labs, Inc.-- -- -- -
What do Analysts Say About THRM.V or COOL.CX?
Therma Bright, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Core One Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Therma Bright, Inc. has higher upside potential than Core One Labs, Inc., analysts believe Therma Bright, Inc. is more attractive than Core One Labs, Inc..
Company Buy Ratings Hold Ratings Sell Ratings THRM.VTherma Bright, Inc.0 0 0 COOL.CXCore One Labs, Inc.0 0 0 -
Is THRM.V or COOL.CX More Risky?
Therma Bright, Inc. has a beta of 1.343, which suggesting that the stock is 34.307% more volatile than S&P 500. In comparison Core One Labs, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.458%.
-
Which is a Better Dividend Stock THRM.V or COOL.CX?
Therma Bright, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Core One Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Therma Bright, Inc. pays -- of its earnings as a dividend. Core One Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THRM.V or COOL.CX?
Therma Bright, Inc. quarterly revenues are --, which are larger than Core One Labs, Inc. quarterly revenues of --. Therma Bright, Inc.'s net income of -$230.9K is higher than Core One Labs, Inc.'s net income of --. Notably, Therma Bright, Inc.'s price-to-earnings ratio is -- while Core One Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Therma Bright, Inc. is 38.02x versus 32.71x for Core One Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THRM.VTherma Bright, Inc.38.02x -- -- -$230.9K COOL.CXCore One Labs, Inc.32.71x -- -- --
-
Which has Higher Returns THRM.V or CURE.X.CX?
Biocure Technology has a net margin of -10816.22% compared to Therma Bright, Inc.'s net margin of --. Therma Bright, Inc.'s return on equity of -2504.22% beat Biocure Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THRM.VTherma Bright, Inc.88.09% -$0.00 -$1.5M CURE.X.CXBiocure Technology-- -- -- -
What do Analysts Say About THRM.V or CURE.X.CX?
Therma Bright, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Biocure Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that Therma Bright, Inc. has higher upside potential than Biocure Technology, analysts believe Therma Bright, Inc. is more attractive than Biocure Technology.
Company Buy Ratings Hold Ratings Sell Ratings THRM.VTherma Bright, Inc.0 0 0 CURE.X.CXBiocure Technology0 0 0 -
Is THRM.V or CURE.X.CX More Risky?
Therma Bright, Inc. has a beta of 1.343, which suggesting that the stock is 34.307% more volatile than S&P 500. In comparison Biocure Technology has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock THRM.V or CURE.X.CX?
Therma Bright, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biocure Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Therma Bright, Inc. pays -- of its earnings as a dividend. Biocure Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THRM.V or CURE.X.CX?
Therma Bright, Inc. quarterly revenues are --, which are larger than Biocure Technology quarterly revenues of --. Therma Bright, Inc.'s net income of -$230.9K is higher than Biocure Technology's net income of --. Notably, Therma Bright, Inc.'s price-to-earnings ratio is -- while Biocure Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Therma Bright, Inc. is 38.02x versus -- for Biocure Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THRM.VTherma Bright, Inc.38.02x -- -- -$230.9K CURE.X.CXBiocure Technology-- -- -- --
-
Which has Higher Returns THRM.V or HEAL.CX?
has a net margin of -10816.22% compared to Therma Bright, Inc.'s net margin of --. Therma Bright, Inc.'s return on equity of -2504.22% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THRM.VTherma Bright, Inc.88.09% -$0.00 -$1.5M HEAL.CX-- -- -- -
What do Analysts Say About THRM.V or HEAL.CX?
Therma Bright, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that Therma Bright, Inc. has higher upside potential than , analysts believe Therma Bright, Inc. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings THRM.VTherma Bright, Inc.0 0 0 HEAL.CX0 0 0 -
Is THRM.V or HEAL.CX More Risky?
Therma Bright, Inc. has a beta of 1.343, which suggesting that the stock is 34.307% more volatile than S&P 500. In comparison has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock THRM.V or HEAL.CX?
Therma Bright, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Therma Bright, Inc. pays -- of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THRM.V or HEAL.CX?
Therma Bright, Inc. quarterly revenues are --, which are larger than quarterly revenues of --. Therma Bright, Inc.'s net income of -$230.9K is higher than 's net income of --. Notably, Therma Bright, Inc.'s price-to-earnings ratio is -- while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Therma Bright, Inc. is 38.02x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THRM.VTherma Bright, Inc.38.02x -- -- -$230.9K HEAL.CX-- -- -- --
-
Which has Higher Returns THRM.V or LOBE.CX?
Lobe Sciences Ltd. has a net margin of -10816.22% compared to Therma Bright, Inc.'s net margin of --. Therma Bright, Inc.'s return on equity of -2504.22% beat Lobe Sciences Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THRM.VTherma Bright, Inc.88.09% -$0.00 -$1.5M LOBE.CXLobe Sciences Ltd.-- -$0.01 $5.9M -
What do Analysts Say About THRM.V or LOBE.CX?
Therma Bright, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Lobe Sciences Ltd. has an analysts' consensus of -- which suggests that it could grow by 14192.33%. Given that Lobe Sciences Ltd. has higher upside potential than Therma Bright, Inc., analysts believe Lobe Sciences Ltd. is more attractive than Therma Bright, Inc..
Company Buy Ratings Hold Ratings Sell Ratings THRM.VTherma Bright, Inc.0 0 0 LOBE.CXLobe Sciences Ltd.0 0 0 -
Is THRM.V or LOBE.CX More Risky?
Therma Bright, Inc. has a beta of 1.343, which suggesting that the stock is 34.307% more volatile than S&P 500. In comparison Lobe Sciences Ltd. has a beta of 0.215, suggesting its less volatile than the S&P 500 by 78.507%.
-
Which is a Better Dividend Stock THRM.V or LOBE.CX?
Therma Bright, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lobe Sciences Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Therma Bright, Inc. pays -- of its earnings as a dividend. Lobe Sciences Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THRM.V or LOBE.CX?
Therma Bright, Inc. quarterly revenues are --, which are smaller than Lobe Sciences Ltd. quarterly revenues of --. Therma Bright, Inc.'s net income of -$230.9K is higher than Lobe Sciences Ltd.'s net income of -$1.1M. Notably, Therma Bright, Inc.'s price-to-earnings ratio is -- while Lobe Sciences Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Therma Bright, Inc. is 38.02x versus -- for Lobe Sciences Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THRM.VTherma Bright, Inc.38.02x -- -- -$230.9K LOBE.CXLobe Sciences Ltd.-- -- -- -$1.1M
-
Which has Higher Returns THRM.V or NSHS.CX?
NanoSphere Health Sciences, Inc. has a net margin of -10816.22% compared to Therma Bright, Inc.'s net margin of --. Therma Bright, Inc.'s return on equity of -2504.22% beat NanoSphere Health Sciences, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital THRM.VTherma Bright, Inc.88.09% -$0.00 -$1.5M NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M -
What do Analysts Say About THRM.V or NSHS.CX?
Therma Bright, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand NanoSphere Health Sciences, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Therma Bright, Inc. has higher upside potential than NanoSphere Health Sciences, Inc., analysts believe Therma Bright, Inc. is more attractive than NanoSphere Health Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings THRM.VTherma Bright, Inc.0 0 0 NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 -
Is THRM.V or NSHS.CX More Risky?
Therma Bright, Inc. has a beta of 1.343, which suggesting that the stock is 34.307% more volatile than S&P 500. In comparison NanoSphere Health Sciences, Inc. has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.292%.
-
Which is a Better Dividend Stock THRM.V or NSHS.CX?
Therma Bright, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NanoSphere Health Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Therma Bright, Inc. pays -- of its earnings as a dividend. NanoSphere Health Sciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios THRM.V or NSHS.CX?
Therma Bright, Inc. quarterly revenues are --, which are smaller than NanoSphere Health Sciences, Inc. quarterly revenues of --. Therma Bright, Inc.'s net income of -$230.9K is lower than NanoSphere Health Sciences, Inc.'s net income of -$13.1K. Notably, Therma Bright, Inc.'s price-to-earnings ratio is -- while NanoSphere Health Sciences, Inc.'s PE ratio is 0.52x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Therma Bright, Inc. is 38.02x versus -- for NanoSphere Health Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income THRM.VTherma Bright, Inc.38.02x -- -- -$230.9K NSHS.CXNanoSphere Health Sciences, Inc.-- 0.52x -- -$13.1K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 29
Galecto, Inc. [GLTO] is down 12.13% over the past day.
Sell
20
SMX alert for Dec 29
SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.
Sell
11
CDNAF alert for Dec 29
Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.
